Aarkstore - Liposomes by Shubhangi

AArkstore enterprise 8th December 2014

Aarkstore â&#x20AC;&#x201C; Liposomes Browse Full Report @ http://www.aarkstore.com/biotechnology/53608/liposomes Published: Apr 2014 | No. Of Pages: 1032 Pages PDF: $ 4860 | Global Licence: $ 10400

Liposomes Market research report gives an insight into global Liposomes market. The report provides market analytics by application, and by therapeutic area. The market is divided by Application into Therapeutic, Cosmetic and Other; and by Therapeutics into Anti fungal, Anticancer, Ophthalmic and Other. The study also provides information regarding products and technologies in the field of Liposomes. Business profiles of 37 major companies are discussed in the report. The report covers more than 330 companies that are engaged in Liposomes research and supply of products and/or services. Compilation of Worldwide Patents and Research related to Liposomes is also provided. Projections and estimates are also illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World with 114 exclusive graphically represented exhibits. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, and other areas of concern is also covered in the report.

Browse complete Report on: http://www.aarkstore.com/biotechnology/53608/liposomes

AArkstore enterprise 20% Discount on all RI Technologies Market Research Reports: Click here and avail Discount offers on Selective market research reports: http://www.aarkstore.com/discount.php Discount Valid till 31st December 2014 For Market Research Reports Call us on: +91 9987295242 OR Mail us at contact@aarkstore.com

Table of Contents: 1. SCOPE AND METHODOLOGY

2. REPORT SYNOPSIS

2.1 Liposomes - Introduction Liposomes - History Liposomes Classification Preparation and Formation of Liposomes Production Process Drug or Solute Encapsulation into Liposomes - Process Liposomes modified with cell-penetrating peptides

AArkstore enterprise Applications 2.2 Segmentation Exhibit 1. Segmentation of Global Liposomes Market by Application Therapeutics Cosmetics Other Exhibit 2. Segmentation of Global Liposomal Therapeutic Market Antifungal Anticancer Ophthalmic Other 2.3 Liposomes - Global Market Analysis Exhibit 3. Liposomes - Global Market Estimations & Predictions (2005- 2020) in US$ Billion Exhibit 4. List of Global Major Liposomes Companies

3. MARKET DYNAMICS

3.1 Market Overview Liposomes and Pharmaceuticals Liposomes and Nanotechnology New Nanoparticles Can Replace Liposomes in Drug Delivery New Methods of Liposomal Drug Delivery

AArkstore enterprise Concerns with Large-scale Production of Liposomal Formulations Lipid based Technologies Lipid based delivery agents in cosmetics Exhibit 5. List of Approved Liposomal Drugs 3.2 Global Liposomes Market Exhibit 6. Liposomes - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 7. Liposomes - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.3 North American Liposomes Market Exhibit 8. Liposomes - North American Market Estimations and Predictions (2005-2020) in US$ Million for United States and Canada (Graphical Representation Included) Exhibit 9. Liposomes - North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 3.3 (I) US Liposomes Market 3.3 (II) Canadian Liposomes Market Exhibit 10. List of Major North American Liposomes Companies 3.4 European Liposomes Market Exhibit 11. Liposomes - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) Exhibit 12. Liposomes - European Market Shares (2010, 2015 & 2020) for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) 3.4 (I) Germany Liposomes Market

AArkstore enterprise 3.4 (II) UK Liposomes Market 3.4 (III) French Liposomes Market 3.4 (IV) Russian Liposomes Market Exhibit 13. List of Major European Liposomes Companies 3.5 Asia-Pacific Liposomes Market Exhibit 14. Liposomes - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) Exhibit 15. Liposomes - Asia-Pacific Market Shares (2010, 2015 & 2020) for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 3.5 (I) Australian Liposomes Market 3.5 (II) Japanese Liposomes Market 3.5 (III) Chinese Liposomes Market 3.5 (IV) Indian Liposomes Market 3.5 (V) South Korean Liposomes Market Exhibit 16. List of Major Asia-Pacific Liposomes Companies 3.6 Rest of World Liposomes Market Exhibit 17. Liposomes - Rest of World Market Estimations and Predictions (2005-2020) by Country for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 18. Liposomes - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.6 (I) Israeli Liposomes Market 3.6 (II) South African Liposomes Market

AArkstore enterprise 3.6 (III) Brazilian Liposomes Market Exhibit 19. List of Major Rest of World Liposomes Companies 3.7 Company Profiles - Major Players in Liposomes Market Advanced Biomedical Ltd. (UK) Aradigm Corporation (USA) Arboretum Skincare (USA) Avanti Polar Lipids, Inc. (USA) Azaya Therapeutics, Inc. (USA) BioZone Laboratories, Inc. (USA) Callisto Pharmaceuticals, Inc. (USA) Celsion Corporation (USA) Chemi SpA (Italy) Moreâ&#x20AC;Ś. 3.8 Major Activities in Liposomes Market Marina Biotech Signs a License Agreement with Mirna Therapeutics for Enhancing Therapeutics Based upon microRNA Aradigm Confirms PulmaquinTM for Phase 3 Development and Receipt of First U.S. Patent for Inhaled Ciprofloxacin formulations Evonik Takes Over the Assets of SurModics Silence Therapeutics Enters Collaboration with Mirna Therapeutics for the Delivery of Innovative microRNA Therapeutics Teva Acquires Cephalon Moreâ&#x20AC;Ś

AArkstore enterprise 3.9 Liposomes - Analysis by Application Exhibit 20. Liposomal Applications - Global Market Estimations and Predictions (2005-2020) in US$ Million for Therapeutics, Cosmetics and Other (Graphical Representation Included) Exhibit 21. Liposomal Applications - Global Market Shares (2010, 2015 & 2020) for Therapeutics, Cosmetics and Other (Graphical Representation Included) 3.9.1 Therapeutics 3.9.1.1 Global Liposomal Therapeutics Market Exhibit 22. Liposomal Therapeutics - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) Exhibit 23. Liposomal Therapeutics - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) 3.9.1.2 North American Liposomal Therapeutics Market Exhibit 24. Liposomal Therapeutics - North American Market Estimations and Predictions (20052020) in US$ Million for United States and Canada (Graphical Representation Included) Exhibit 25. Liposomal Therapeutics - North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 3.9.1.2 (I) US Liposomal Therapeutics Market 3.9.1.2 (II) Canadian Liposomal Therapeutics Market Exhibit 26. List of Major North American Liposomal Therapeutics Companies 3.9.1.3 European Liposomal Therapeutics Market Exhibit 27. Liposomal Therapeutics - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) Exhibit 28. Liposomal Therapeutics - European Market Shares (2010, 2015 & 2020) for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included)

AArkstore enterprise 3.9.1.3 (I) Germany Liposomal Therapeutics Market 3.9.1.3 (II) UK Liposomal Therapeutics Market 3.9.1.3 (III) French Liposomal Therapeutics Market 3.9.1.3 (IV) Russian Liposomal Therapeutics Market Exhibit 29. List of Major European Liposomal Therapeutics Companies 3.9.1.4 Asia-Pacific Liposomal Therapeutics Market Exhibit 30. Liposomal Therapeutics - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) Exhibit 31. Liposomal Therapeutics - Asia-Pacific Market Shares (2010, 2015 & 2020) for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 3.9.1.4 (I) Australian Liposomal Therapeutics Market 3.9.1.4 (II) Japanese Liposomal Therapeutics Market 3.9.1.4 (III) Chinese Liposomal Therapeutics Market 3.9.1.4 (IV) Indian Liposomal Therapeutics Market 3.9.1.4 (V) South Korean Liposomal Therapeutics Market Exhibit 32. List of Major Asia-Pacific Liposomal Therapeutics Companies 3.9.1.5 Rest of World Liposomal Therapeutics Market Exhibit 33. Liposomal Therapeutics - Rest of World Market Estimations and Predictions (20052020) by Country for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 34. Liposomal Therapeutics - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)

AArkstore enterprise 3.9.1.5 (I) Israeli Liposomal Therapeutics Market 3.9.1.5 (II) South African Liposomal Therapeutics Market 3.9.1.5 (III) Brazilian Liposomal Therapeutics Market Exhibit 35. List of Major Rest of World Liposomal Therapeutics Companies 3.9.2 Cosmetics 3.9.2.1 Global Liposomal Cosmetics Market Exhibit 36. Liposomal Cosmetics - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) Exhibit 37. Liposomal Cosmetics - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) 3.9.2.2 North American Liposomal Cosmetics Market Exhibit 38. Liposomal Cosmetics - North American Market Estimations and Predictions (20052020) in US$ Million for United States and Canada (Graphical Representation Included) Exhibit 39. Liposomal Cosmetics - North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 3.9.2.2 (I) US Liposomal Cosmetics Market 3.9.2.2 (II) Canadian Liposomal Cosmetics Market Exhibit 40. List of Major North American Liposomal Cosmetics Companies 3.9.2.3 European Liposomal Cosmetics Market Exhibit 41. Liposomal Cosmetics - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) Exhibit 42. Liposomal Cosmetics - European Market Shares (2010, 2015 & 2020) for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included)

AArkstore enterprise 3.9.2.3 (I) Germany Liposomal Cosmetics Market 3.9.2.3 (II) UK Liposomal Cosmetics Market 3.9.2.3 (III) French Liposomal Cosmetics Market 3.9.2.3 (IV) Russian Liposomal Cosmetics Market Exhibit 43. List of Major European Liposomal Cosmetics Companies 3.9.2.4 Asia-Pacific Liposomal Cosmetics Market Exhibit 44. Liposomal Cosmetics - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) Exhibit 45. Liposomal Cosmetics - Asia-Pacific Market Shares (2010, 2015 & 2020) for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 3.9.2.4 (I) Australian Liposomal Cosmetics Market 3.9.2.4 (II) Japanese Liposomal Cosmetics Market 3.9.2.4 (III) Chinese Liposomal Cosmetics Market 3.9.2.4 (IV) Indian Liposomal Cosmetics Market 3.9.2.4 (V) South Korean Liposomal Cosmetics Market Exhibit 46. List of Major Asia-Pacific Liposomal Cosmetics Companies 3.9.2.5 Rest of World Liposomal Cosmetics Market Exhibit 47. Liposomal Cosmetics - Rest of World Market Estimations and Predictions (2005-2020) by Country for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 48. Liposomal Cosmetics - Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.9.2.5 (I) Israeli Liposomal Cosmetics Market

AArkstore enterprise 3.9.2.5 (II) South African Liposomal Cosmetics Market 3.9.2.5 (III) Brazilian Liposomal Cosmetics Market Exhibit 49. List of Major Rest of World Liposomal Cosmetics Companies 3.9.3 Other Applications 3.9.3.1 Global Other Liposomal Applications Market Exhibit 50. Other Liposomal Applications - Global Market Estimations and Predictions (20052020) in US$ Million for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) Exhibit 51. Other Liposomal Applications - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) 3.9.3.2 North American Other Liposomal Applications Market Exhibit 52. Other Liposomal Applications - North American Market Estimations and Predictions (2005-2020) in US$ Million for United States and Canada (Graphical Representation Included) Exhibit 53. Other Liposomal Applications - North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 3.9.3.3 European Other Liposomal Applications Market Exhibit 54. Other Liposomal Applications - European Market Estimations and Predictions (20052020) in US$ Million for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) Exhibit 55. Other Liposomal Applications - European Market Shares (2010, 2015 & 2020) for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) 3.9.3.4 Asia-Pacific Other Liposomal Applications Market Exhibit 56. Other Liposomal Applications - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Australia, Japan, China, India, South Korea and Rest of AsiaPacific (Graphical Representation Included)

AArkstore enterprise Exhibit 57. Other Liposomal Applications - Asia-Pacific Market Shares (2010, 2015 & 2020) for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 3.9.3.5 Rest of World Other Liposomal Applications Market Exhibit 58. Other Liposomal Applications - Rest of World Market Estimations and Predictions (2005-2020) by Country for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 59. Other Liposomal Applications - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.10 Liposomes - Analysis by Therapeutic Area Exhibit 60. Liposomal Therapeutics - Global Market Estimations and Predictions (2005-2020) in US$ Million for Antifungal, Anticancer, Ophthalmic and Other (Graphical Representation Included) Exhibit 61. Liposomal Therapeutics - Global Market Shares (2010, 2015 & 2020) for Antifungal, Anticancer, Ophthalmic and Other (Graphical Representation Included) 3.10.1 Antifungal

List of Tables

3.10.1.1 Global Liposomal Antifungal Therapeutics Market Exhibit 62. Liposomal Antifungal Therapeutics - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) Exhibit 63. Liposomal Antifungal Therapeutics - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) 3.10.1.2 North American Liposomal Antifungal Therapeutics Market

AArkstore enterprise Exhibit 64. Liposomal Antifungal Therapeutics - North American Market Estimations and Predictions (2005-2020) in US$ Million for United States and Canada (Graphical Representation Included) Exhibit 65. Liposomal Antifungal Therapeutics - North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 3.10.1.2 (I) US Liposomal Antifungal Therapeutics Market 3.10.1.2 (II) Canadian Liposomal Antifungal Therapeutics Market Exhibit 66. List of Major North American Liposomal Antifungal Therapeutics Companies 3.10.1.3 European Liposomal Antifungal Therapeutics Market Exhibit 67. Liposomal Antifungal Therapeutics - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) Exhibit 68. Liposomal Antifungal Therapeutics - European Market Shares (2010, 2015 & 2020) for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) 3.10.1.3 (I) Germany Liposomal Antifungal Therapeutics Market 3.10.1.3 (II) UK Liposomal Antifungal Therapeutics Market 3.10.1.3 (III) French Liposomal Antifungal Therapeutics Market 3.10.1.3 (IV) Russian Liposomal Antifungal Therapeutics Market Exhibit 69. List of Major European Liposomal Antifungal Therapeutics Companies 3.10.1.4 Asia-Pacific Liposomal Antifungal Therapeutics Market Exhibit 70. Liposomal Antifungal Therapeutics - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Australia, Japan, China, India, South Korea and Rest of AsiaPacific (Graphical Representation Included)

AArkstore enterprise Exhibit 71. Liposomal Antifungal Therapeutics - Asia-Pacific Market Shares (2010, 2015 & 2020) for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 3.10.1.4 (I) Australian Liposomal Antifungal Therapeutics Market 3.10.1.4 (II) Japanese Liposomal Antifungal Therapeutics Market 3.10.1.4 (III) Chinese Liposomal Antifungal Therapeutics Market 3.10.1.4 (IV) Indian Liposomal Antifungal Therapeutics Market 3.10.1.4 (V) South Korean Liposomal Antifungal Therapeutics Market Exhibit 72. List of Major Asia-Pacific Liposomal Antifungal Therapeutics Companies 3.10.1.5 Rest of World Liposomal Antifungal Therapeutics Market Exhibit 73. Liposomal Antifungal Therapeutics - Rest of World Market Estimations and Predictions (2005-2020) by Country for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 74. Liposomal Antifungal Therapeutics - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.10.1.5 (I) Israeli Liposomal Antifungal Therapeutics Market 3.10.1.5 (II) South African Liposomal Antifungal Therapeutics Market 3.10.1.5 (III) Brazilian Liposomal Antifungal Therapeutics Market Exhibit 75. List of Major Rest of World Liposomal Antifungal Therapeutics Companies 3.10.2 Anticancer 3.10.2.1 Global Liposomal Anticancer Therapeutics Market Exhibit 76. Liposomal Anticancer Therapeutics - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included)

AArkstore enterprise Exhibit 77. Liposomal Anticancer Drugs - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) 3.10.2.2 North American Liposomal Anticancer Therapeutics Market Exhibit 78. Liposomal Anticancer Therapeutics - North American Market Estimations and Predictions (2005-2020) in US$ Million for United States and Canada (Graphical Representation Included) Exhibit 79. Liposomal Anticancer Therapeutics - North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 3.10.2.2 (I) US Liposomal Anticancer Therapeutics Market 3.10.2.2 (II) Canadian Liposomal Anticancer Therapeutics Market Exhibit 80. List of Major North American Liposomal Anticancer Therapeutics Companies 3.10.2.3 European Liposomal Anticancer Therapeutics Market Exhibit 81. Liposomal Anticancer Therapeutics - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) Exhibit 82. Liposomal Anticancer Therapeutics - European Market Shares (2010, 2015 & 2020) for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) 3.10.2.3 (I) Germany Liposomal Anticancer Therapeutics Market 3.10.2.3 (II) UK Liposomal Anticancer Therapeutics Market 3.10.2.3 (III) French Liposomal Anticancer Therapeutics Market 3.10.2.3 (IV) Russian Liposomal Anticancer Therapeutics Market Exhibit 83. List of Major European Liposomal Anticancer Therapeutics Companies 3.10.2.4 Asia-Pacific Liposomal Anticancer Therapeutics Market

AArkstore enterprise Exhibit 84. Liposomal Anticancer Therapeutics - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Australia, Japan, China, India, South Korea and Rest of AsiaPacific (Graphical Representation Included) Exhibit 85. Liposomal Anticancer Therapeutics - Asia-Pacific Market Shares (2010, 2015 & 2020) for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 3.10.2.4 (I) Australian Liposomal Anticancer Therapeutics Market 3.10.2.4 (II) Japanese Liposomal Anticancer Therapeutics Market 3.10.2.4 (III) Chinese Liposomal Anticancer Therapeutics Market 3.10.2.4 (IV) Indian Liposomal Anticancer Therapeutics Market 3.10.2.4 (V) South Korean Liposomal Anticancer Therapeutics Market Exhibit 86. List of Major Asia-Pacific Liposomal Anticancer Therapeutics Companies 3.10.2.5 Rest of World Liposomal Anticancer Therapeutics Market Exhibit 87. Liposomal Anticancer Therapeutics - Rest of World Market Estimations and Predictions (2005-2020) by Country for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 88. Liposomal Anticancer Therapeutics - Rest of World Market Shares (2010, 2015 & 2020) for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 3.10.2.5 (I) Israeli Liposomal Anticancer Therapeutics Market 3.10.2.5 (II) South African Liposomal Anticancer Therapeutics Market 3.10.2.5 (III) Brazilian Liposomal Anticancer Therapeutics Market Exhibit 89. List of Major Rest of World Liposomal Anticancer Therapeutics Companies 3.10.3 Opthalmic 3.10.3.1 Global Liposomal Ophthalmic Therapeutics Market

AArkstore enterprise Exhibit 90. Liposomal Ophthalmic Therapeutics - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) Exhibit 91. Liposomal Ophthalmic Therapeutics - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) 3.10.3.2 North American Liposomal Ophthalmic TherapeuticsMarket Exhibit 92. Liposomal Ophthalmic Therapeutics - North American Market Estimations and Predictions (2005-2020) in US$ Million for United States and Canada (Graphical Representation Included) Exhibit 93. Liposomal Ophthalmic Therapeutics - North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 3.10.3.2 (I) US Liposomal Ophthalmic Therapeutics Market 3.10.3.2 (II) Canadian Liposomal Ophthalmic Therapeutics Market Exhibit 94. List of Major North American Liposomal Ophthalmic Therapeutics Companies 3.10.3.3 European Liposomal Ophthalmic Therapeutics Market Exhibit 95. Liposomal Ophthalmic Therapeutics - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) Exhibit 96. Liposomal Ophthalmic Therapeutics - European Market Shares (2010, 2015 & 2020) for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) 3.10.3.3 (I) Germany Liposomal Ophthalmic Therapeutics Market 3.10.3.3 (II) UK Liposomal Ophthalmic Therapeutics Market 3.10.3.3 (III) French Liposomal Ophthalmic Therapeutics Market 3.10.3.3 (IV) Russian Liposomal Ophthalmic Therapeutics Market Exhibit 97. List of Major European Liposomal Ophthalmic Therapeutics Companies

AArkstore enterprise 3.10.3.4 Asia-Pacific Liposomal Ophthalmic Therapeutics Market Exhibit 98. Liposomal Ophthalmic Therapeutics - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Australia, Japan, China, India, South Korea and Rest of AsiaPacific (Graphical Representation Included) Exhibit 99. Liposomal Ophthalmic Therapeutics - Asia-Pacific Market Shares (2010, 2015 & 2020) for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 3.10.3.4 (I) Australian Liposomal Ophthalmic Therapeutics Market 3.10.3.4 (II) Japanese Liposomal Ophthalmic Therapeutics Market 3.10.3.4 (III) Chinese Liposomal Ophthalmic Therapeutics Market 3.10.3.4 (IV) Indian Liposomal Ophthalmic Therapeutics Market 3.10.3.4 (V) South Korean Liposomal Ophthalmic Therapeutics Market Exhibit 100. List of Major Asia-Pacific Liposomal Ophthalmic Therapeutics Companies 3.10.3.5 Rest of World Liposomal Ophthalmic Therapeutics Market Exhibit 101. Liposomal Ophthalmic Therapeutics - Rest of World Market Estimations and Predictions (2005-2020) by Country for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 102. Liposomal Ophthalmic Therapeutics - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.10.3.5 (I) Israeli Liposomal Ophthalmic Therapeutics Market 3.10.3.5 (II) South African Liposomal Ophthalmic Therapeutics Market 3.10.3.5 (III) Brazilian Liposomal Ophthalmic Therapeutics Market Exhibit 103. List of Major Rest of World Liposomal Ophthalmic Therapeutics Companies

AArkstore enterprise List of Figures

3.10.4 Other Therapeutics 3.10.4.1 Global Market for Other Liposomal Therapeutics Exhibit 104. Other Liposomal Therapeutics - Global Market Estimations and Predictions (20052020) in US$ Million for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) Exhibit 105. Other Liposomal Therapeutics - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific, and Rest of World (Graphical Representation Included) 3.10.1.2 North American Market for Other Liposomal Therapeutics Exhibit 106. Other Liposomal Therapeutics - North American Market Estimations and Predictions (2005-2020) in US$ Million for United States and Canada (Graphical Representation Included) Exhibit 107. Other Liposomal Therapeutics - North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 3.10.4.3 European Market for Other Liposomal Therapeutics Exhibit 108. Other Liposomal Therapeutics - European Market Estimations and Predictions (20052020) in US$ Million for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) Exhibit 109. Other Liposomal Therapeutics - European Market Shares (2010, 2015 & 2020) for Germany, United Kingdom, France, Russia and Rest of Europe (Graphical Representation Included) 3.10.4.4 Asia-Pacific Market for Other Liposomal Therapeutics Exhibit 110. Other Liposomal Therapeutics - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Australia, Japan, China, India, South Korea and Rest of AsiaPacific (Graphical Representation Included)

AArkstore enterprise Exhibit 111. Other Liposomal Therapeutics - Asia-Pacific Market Shares (2010, 2015 & 2020) for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 3.10.4.5 Rest of World Market for Other Liposomal Therapeutics Exhibit 112. Other Liposomal Therapeutics - Rest of World Market Estimations and Predictions (2005-2020) by Country for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 113. Other Liposomal Therapeutics - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11 Liposomes - Market Outlook

4. PRODUCT/TECHNOLOGY RESEARCH

4.1 Introduction Liposomes Forms of Liposomes Various forms of liposomes Stealth Liposomes Novel Liposomes Magnetic Liposomes: Cytoskeleton-Specific Immunoliposomes: Liposomal Hemoglobin: ATP Liposomes: Classification

AArkstore enterprise Applications of Size and Zeta Potential Properties Liposomes in Drug Delivery Factors Affecting Stability of Liposomes Liposome - Constitution, Activities and Improvements C-Terminal Substitution of Amino Acids / Peptides: Features of N-linked Glycosylation: Role of Ligands in Liposome Therapy: Techniques for Forming Stable Liposomes Liposome- Understanding Various Effects on Liposomal Membrane Effects of Bilayer Lipid Membrane (BLM) Stretch on N-Methyl-D- Aspartate (NMDA): Effects of Fusion Process on Liposomes Membrane: Effects of Stimuli Receptive, Protein & Polymer on Liposome Membranes: Effects of Melittin-Induced Membrane Fusion on Liposome Membranes: Pharmacokinetics - Liposomes Role Michaelis-Menten Equation: Various Factors Affecting the Liposome Pharmacokinetics Size of Liposome Dosage of Liposome Lipid Composition of Liposome Measurement of Liposomes DLS technique of Analyzing Liposome Size

AArkstore enterprise Factors Associated with Liposome Measurement Liposome - Preparation Process Convectional Process Merits and Demerits of Conventional liposomes Sonication Process The High-Pressure Extrusion Process The Solubilisation and Detergent Removal Process Homogenization The Reverse Phase Evaporation Method Unilamellar Liposomal Vesicles Production using Highly Active Ingredients Lyophilization Process Lyophilization of Double Emulsions Lyophilization of Monophase Solution Producing Liposomes using Spray-Drying Technique Salient Features of a Commercially Available Liposome Spray Superficial Reverse Phase Evaporation Process using Supercritical Carbon Dioxide Advantages and Disadvantages Advantages of Liposomes Advantages of Liposomes in Pharmaceutical Industry Advantages of Liposomes in Food Industry Disadvantages of Liposomes Uses

AArkstore enterprise The Versatility of Liposome Nanovesicles is Possible Because of Two Important Features of the Nanovesicles: Use Of Liposomes In Bioanalysis Lateral Flow Electrochemical Assay Formats Liposomes and Hydrophilic, Amphiphilic And Lipophilic Substances Benefits of Using Liposomes in Skincare Products Use of Applied Phospholipids in Food and Cosmetics Use of Lipid Liposomes as Carriers for Delivery of Oral Vaccines. Liposomes In Medicine Uses of Liposomal Drug Delivery Systems Injectable-Drug Delivery Systems Use of Liposomes Containing Carbohydrates for Production of Monoclonal Antibodies Therapeutic Uses of Antioxidant Liposomes Use of Phospholipid Bilayers and Monolayers in Binding Studies of Vitamin K-Dependent Blood Coagulation Proteins 4.2 Application Area Therapeutics Various Diseases - Role of Liposomes Exhibit 114. List of Liposome based drugs in Clinical Trials Targeted Liposomal Drug Delivery to Monocytes and Macrophages Anti Fungal Liposomal Amphotericin B Availed In Bone Marrow Transplant

AArkstore enterprise Anti Fungal Drugs Abelcet Liposomal Amphotericin B Anticancer Liposomal Drug Delivery -- Hyperthermia Mediated Liposomes That Are Tumor-Targeted Make Clinical Headway Cancer and Boron Neutron Capture Therapy Ovarian Cancer and Liposomal Doxorubicin Cancer Treatment with Cisplatin Encapsulated Nanoliposomes Brain Cancer Diagnosis and Treatment Using Nanomedicine Anti-PSMA-Liposome-Complex in Cancer Therapy Photodynamic Therapy to Treat Tumor Application of Liposome/Anthraquinone Drug Composition in Treatment of Neoplasm Cases Pegylated Liposomal Doxorubicin in Treating a Case of Advanced Hepatocellular Carcinoma with Severe Hepatic Dysfunction and Pharmacokinetic Study New Generation Liposomes for Cancer Therapy Anti Cancer Drugs Liposomal Doxorubicin Doxorubicin Pegylated Liposomal Doxorubicin DaunoXome DepoCyt

AArkstore enterprise Lipusu Ophthalmic Application of Liposomes in Ophthalmic Drug Delivery Other Therapeutic Applications of Liposomes Vaccines Influenza Inflexal V: Liposomal Influenza Vaccine or INFLUSOME-VAC Hepatitis Liposomal Hepatitis A Vaccine and Liposomal Multiantigen Combination Vaccines Epaxal Antiparasitics Liposomes as Remedy for Malaria Liposomal Formulation for Control of Parasitemia and Safeguard from Plasmodium berghei Liposome Carriers in Chemotherapy of Leishmaniasis Cardiovascular Diseases Cerebral Ischemia and Stroke Dermatology Analgesics Dispatch of Vesicle in Dental Treatment Treatment of Inflammation by Applying Targeted Therapy Using Liposomes Use of Liposome Delivery System to Convey Drugs to Sites of Inflammation

AArkstore enterprise Application of Liposomes in Treatment of Pulmonary Disorders Liposomes in AIDS Therapy Liposome - A Immunological Adjuvant Liposomes and Immunoassays Cosmetics Natural Liposomes Liposomes as Carriers in Cosmetics Chemical Composition and Physiochemical Characteristics of Liposomes Conducive for Skin Care and Treatment Liposome as a Cleaning Composition â&#x20AC;&#x201C;Facial Cleanser Other Applications Agro Food Liposomal Formulations in Agricultural Pesticides Liposome-Encapsulated Enzyme Accelerates Ripening of Cheese Textile Industry Technological Innovation on Textile Dyeing using Liposomes Dyeing of Wool with Madder and Liposomes Neutraceuticals Diagnostics Liposome as an Imaging Tool Liposomes Used For Radiopharmaceuticals The Use of Liposome-Mediated Radiotherapeutics Inside Avascular Tumor Spheroids

AArkstore enterprise Tracer Dose of Technetium-99m-Labeled Liposome And The Estimation Of The Effect Of Hyperthermia on Intratumoral Doxil Extravasation The Targeting Of Radiopharmaceuticals to Tumor with The use of Liposomes as Carrier The Use of Liposomes as Contrast Agents for Ultrasonic Imaging Temperature Sensitive Liposomes for Local Drug Delivery Utilizing Focused Ultrasound Liposomes Used as Contrast Agents for Ultrasonic Imaging Gas Filled Liposomes Used as Ultrasonic Contrast Agents Liposomes that are 99m Tc Labeled The Heated Liposome Drug Delivery - Effects Visualised In Vivo through Magnetic Resonance Imaging Ultrasound-Guided Liposomes Assist Imaging, Target Drug/Gene Therapy Liposomes in Genetic Engineering Application of Phospholipid Liposomes In Healing Post Menopausal Mood Disorders The Potential of Immunocontraception Especially in Coyote Management Other Applications Future Trends and Applications Plant-Based Substances for Skin Care Using Plants Possessing another Type of Characteristics for Restraining Tyrosinase 4.3 Government Regulations 4.4 Liposomes - Research Briefs Mass Production of Lipid Powder Containing Liposomes and Encapsulating Material Liposomes as Conveyors of Drugs In the Treatment of Allergic Diseases

AArkstore enterprise Process for Producing Proteoliposomes Inactivated Tissue Plasminogen Activator to Target Echogenic Liposomes Experimental Design to Optimize Formulation Variables of Benzocaine Liposomes Effect of Drug-to-Lipid on Drug Release and Effect of Liposome Integrity in Liposomal Doxorubicin Formulations Efficiency of Epidermal Growth Factor Encapsulated in Dehydration Rehydration Vesicles of Different Phospholipid Composition Moreâ&#x20AC;Ś.. V. CORPORATE DIRECTORY VI. PATENTS INFORMATION

Discounted Market Research reports:

Prions Biotechnology in India Glucosamine Intravenous Solutions DNA Sequencing hERG Screening Biochips Bionanotechnology Biological Implants Biotechnology Market Research Reports

AArkstore enterprise About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

You can order full Report with TOC and Sample page visit

http://www.aarkstore.com/biotechnology/53608/liposo mes

Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 / 022-27564953 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com

AArkstore enterprise